Background: The relationship between allergy and autoimmune disorders is complex and poorly understood. Objective: We sought to investigate commonalities in genetic loci and pathways between allergy and autoimmune diseases to elucidate shared disease mechanisms.
for enrichment within genetic pathways and of transcription factor binding sites and characterized commonalities in variant burden on tissue-specific regulatory sites by calculating the enrichment of allergy SNPs falling in gene regulatory regions in various cells using Encode Roadmap DNase-hypersensitive site data. Finally, we compared the allergy data with those of all known diseases. Results: Among 290 loci previously associated with 16 autoimmune diseases, we found a significant enrichment of loci also associated with allergy (P 5 1.4e-17) encompassing 29 loci at a false discovery rate of less than 0.05. Such enrichment seemed to be a general characteristic for autoimmune diseases. Among the common loci, 48% had the same direction of effect for allergy and autoimmune diseases. Additionally, we observed an enrichment of allergy SNPs falling within immune pathways and regions of chromatin accessible in immune cells that was also represented in patients with autoimmune diseases but not those with other diseases. Conclusion: We identified shared susceptibility loci and commonalities in pathways between allergy and autoimmune diseases, suggesting shared disease mechanisms. Further studies of these shared genetic mechanisms might help in understanding the complex relationship between these diseases, including the parallel increase in disease prevalence. (J Allergy Clin Immunol 2017;140:771-81.)
Key words: Allergy, single nucleotide polymorphism, autoimmune disease, autoimmunity, genetic association studies There has been a parallel increase in allergic and autoimmune disorders in recent decades in ''westernized'' countries, 1 suggesting that these diseases might share disease mechanisms and causes. In line with this, allergy and autoimmune disorders seem to share environmental risk factors, including birth by means of caesarian section. 2 This observation is in apparent contrast to the understanding of allergy and autoimmune diseases as representatives of distinct immunologic disorders with counteracting underlying immune mechanisms. Autoimmune diseases are in general thought to act through a T H 1/T H 17-driven cellmediated immune response, 3 whereas allergy and asthma encompass a T H 2-mediated response. 4 Counteracting immune mechanisms have been supported by some epidemiologic studies of comorbidity, suggesting a lower incidence of allergy among patients with autoimmune diseases, including rheumatoid arthritis 5, 6 and multiple sclerosis, 7 although the evidence of such an inverse relationship is conflicting. 8 Both allergy and autoimmune diseases are highly heritable diseases, and an increasing number of susceptibility loci have been discovered. [9] [10] [11] We hypothesized that studying commonalities in the genetic architecture could provide a key to understanding the complex relationship between these diseases by pinpointing possible common disease mechanisms. In a wider perspective this might help to explain the mechanisms and etiologies responsible for the contemporaneous dramatic increase in the incidence of allergic and autoimmune disorders. 1 We studied commonalities between allergy and autoimmune disease in terms of susceptibility loci, genetic pathways, and regulatory mechanisms. We meta-analyzed 2 genome-wide association studies (GWASs) on allergic sensitization and selfreported allergy. These data were then combined with publically available GWAS data on autoimmune diseases, as well as public data on molecular pathways, transcription factor binding sites, and regulatory DNA regions. The primary analyses used a methodological approach that was agnostic to the direction of effect (including loci at which the risk allele was the same for allergy and autoimmune disease and loci at which the risk allele for one disease was protective for the other). We hypothesized that loci with the same direction of effect for different diseases might be involved in shared mechanisms and thereby help us understand the parallel epidemics of diseases, whereas loci with an opposite direction of effect might help with understanding any counteracting (diverging) disease mechanisms. In analogue gene variants in b-adrenoreceptors are likely to show diverging effects with respect to risk of cardiac and respiratory diseases but still pinpoint an essential mechanism for both diseases. For allergy and autoimmune diseases, such loci might be involved in ''polarization'' of the immune response. Therefore we chose an approach that would capture common genetic loci with both the same and opposite directions of effect because we believe that both might confer important information and thereby help elucidate the complex mechanistic relationship between these diseases.
METHODS

Study group
To obtain the largest possible GWAS data set for allergy, we metaanalyzed results from 2 recent GWASs on self-reported allergy 9 and sensitization, 10 including approximately 2.2 million directly genotyped and imputed single nucleotide polymorphisms (SNPs), by using a fixed-effects model. The self-reported allergy data set comprised 23,335 patients with self-reported allergy for cat, dust mite, and/or pollen allergy and 26,311 control subjects without symptoms. The allergic sensitization data set included 5,809 subjects with allergic sensitization defined based on either results of skin prick tests or specific IgE measurements and 9,875 control subjects without allergic sensitization with data from the following cohorts: AAGC, ALSPAC, B58C, COPSAC2000, LISA, MAAS, NFBC 1966, RAINE, and PIAMA (see the Methods section in this article's Online Repository at www.jacionline.org).
Common genetic loci
To identify common genetic loci, we identified SNPs previously shown to be associated with autoimmune diseases from the National Human Genome Research Institute GWAS catalog. 12 The most significant SNP associated with autoimmune diseases (the index disease, one of 16 different diseases) was chosen from each locus defined by genetic distance (see the Methods section in this article's Online Repository), leaving 290 candidate SNPs that were subsequently extracted from the allergy meta-analysis results (see the Methods section, Table E1 , and Fig E1 in this article's Online Repository at www. jacionline.org). For each SNP, the direction of effect of the risk allele for allergy was compared with the direction of effect for the index autoimmune disease, as well as for other autoimmune diseases with reported loci in high linkage disequilibrium.
Among these autoimmune disease-associated SNPs (loci), we calculated an enrichment of significant SNPs in relation to allergy (P < .05) compared with expected values under the null hypothesis. Enrichment was only calculated for diseases with at least 10 loci associated with the index disease and therefore not calculated for systemic sclerosis, sarcoidosis, primary sclerosing cholangitis, and myasthenia gravis. As a methodological negative control, SNPs related to 2 noninflammatory phenotypes, migraine and the combination of bipolar disorder and schizophrenia, with reasonable GWAS sizes, from the GWAS catalog were analyzed similarly.
Commonalities in genetic pathways
To investigate commonalities in functional origins, the data-driven expression prioritized integration for complex traits (DEPICT) gene set enrichment method 13 was applied to 123 diseases and traits in the GWAS catalog, as well as the current association data set on allergy, by analyzing gene set enrichments for 14,416 reconstituted gene sets capturing a wide spectrum of molecular pathways, functional annotations, and mouse phenotypes. For visualization purposes, the resulting enrichment matrix was reduced to fewer dimensions by using principal component analysis (PCA; see Table E2 and the Methods section in this article's Online Repository). Similarly, this approach was applied to the common loci between allergy and autoimmune diseases and to allergy and Crohn disease separately to identify common and disease-specific networks (see the Methods section in this article's Online Repository). Crohn disease was used as a representative of autoimmune diseases because this represents the largest with respect to sample size of the public available GWAS data set to date of an autoimmune disease.
14 Also, we consider this a good representative of autoimmune diseases because it is considered a T H 1-driven immune disease, as are most autoimmune diseases.
The enrichment of transcription factor binding sites in loci common between patients with allergy and those with autoimmune diseases was calculated with ENCODE data by assessing the overlap between loci and binding sites for 161 transcription factors compared with random expectations (see the Methods section in this article's Online Repository).
Common disease-implicated cell types
The tendency of disease-associated loci to decrease in cell type-specific regulatory DNase-hypersensitive sites (DHSs; a proxy for accessible and/or regulatory DNA) was calculated for all diseases in the GWAS catalog, as well as allergy, based on the current association data set to identify and visualize common disease-implicated cell types. This enrichment was computed for 168 cell types and cell lines (hereafter described as cells) from the ENCODE Roadmap repository. 15 Duplicates and directly redundant cell types were removed before analyses. As with pathway enrichments, the resulting enrichment matrix was reduced to fewer dimensions by using PCA for visualization (see the Methods section in this article's Online Repository). For allergy, this was also compared for the full range of P values within the allergy metaanalysis in bins of decreasing P value thresholds, essentially as done by Maurano et al. 16 This was done similarly for Crohn disease for comparison 14 by using data from a GWAS metanalysis 14 including data from 6 studies of European descent with a total of 6,333 cases and 15,056 control subjects in the discovery imputed with HapMap III or II with a total of 953,242 autosomal SNPs. The DHS enrichment was recalculated for enhancer regions in data from the more conservative FANTOM5 set to validate specific findings. 17 
RESULTS
Allergy meta-analysis
Using the joint meta-analysis on combined data from allergic sensitization and self-reported allergy, we increased the number of allergy-associated SNPs compared with the previous GWAS (see Fig One of these, rs11122898 near ANAPC1/MERKT (P 5 1.9e-8), has not previously been associated with allergy or any related trait. In addition, there were 5 novel suggestive loci (P < e-5): rs7612543 near ZBTB38 (P 5 1.0e-7), rs9790601 near NFKB1 (P 5 7.4e-8), rs7072398 near IL2RA (P 5 5.2e-7), rs12365699 near CXCR5 (P 5 6.5e-7), and rs12900122 near RORA (P 5 3.5e-7; see Fig E4 and Table E3 in this article's Online Repository at www.jacionline.org). Notably, all of these suggestive loci have previously been described in relation to autoimmune disorders. 11, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Commonalities in genetic loci, pathways, and disease-implicated cell types between allergy and autoimmune diseases
There was a significant enrichment of autoimmuneassociated loci with low P values among the allergy loci from the current meta-analysis compared with expected values Table I; and see Table E4 in this article's Online Repository at www.jacionline.org). A similar enrichment was seen for the 2 allergy phenotypes separately (self-reported allergy: (Fig 1, A) , although it was not statistically significant for systemic lupus erythematosus and ankylosing spondylitis and for psoriasis and Graves disease after adjusting for multiple testing (Table I) . We a priori chose a P value threshold for the calculations of enrichment of less than 0.05. Using lower thresholds (P < .01 or .001) generally resulted in higher and statistically significant enrichment for all autoimmune diseases (see Table E4 ).
As a methodological negative control, SNPs related to 2 noninflammatory phenotypes with a large number of known genome-wide significant loci, migraine, and the combination of bipolar disorder and schizophrenia from the GWAS catalog were extracted from the allergy meta-analysis. These showed no significant overlap with allergy loci (see Figs E6 and E7 in this article's Online Repository at www.jacionline.org).
Using DEPICT to identify significantly enriched reconstituted gene sets for allergy (see Table E5 in this article's Online Repository at www.jacionline.org) and all diseases in the GWAS catalog, we identified a strong separation of autoimmune diseases, 
Specific common genetic loci
Of the 290 autoimmune disease SNPs investigated, 29 were significantly associated with allergy at a false discovery rate of less than 0.05 (Table II) . Eleven of these common loci (C11ORF30, LPP, PLCL1, HLA-B, SMAD3, IKZF3, MYC, CLEC16A, NDFIP1, BACH2, and IL2RA/IL15RA) were already reported to be associated with allergy (Table II and see Tables E6  and E7 in this article's Online Repository at www.jacionline. org). 9, 10, 31, 32 The remaining 18 overlapping loci included the following mapped genes: NFKB1, SH2B3, AKAP11/TNFSF11, ABO, C12ORF30, CD247, RADSNB, EP300, RORC, PSMG1, HDAC7/VDR, HLA-DPB2, TNFAIP3, KIF1B, RPS6KA4, ERBB3, THADA, and GLB1/CCR4. Look up of the 29 common loci in the separate results from the 2 different allergy phenotypes (allergic symptoms and allergic sensitization) generally showed similar results, including the same direction of effect for the 2 allergy phenotypes for 28 of 29 loci (see Table E6 ). For the majority of loci, the effect size was higher for allergic sensitization compared with allergic symptoms, as would be expected because of the more homogeneous phenotype, and for the majority of loci with evidence of heterogeneity between phenotypes, heterogeneity was due to this. The NDFIP1 locus seemed to be associated only with self-reported allergy.
Comparison of the direction of effect between allergy and autoimmune disease was possible for 27 of the 29 common loci compared with the index autoimmune disease. For 13 (48%) of these, we found the same direction of effect, meaning that the allele increasing the risk of allergy also increases the risk of the autoimmune disease (Table II) . For the remaining 14 (52%) loci, we found an opposite direction of effect, with the risk allele for allergy being associated with reduced risk of the index autoimmune disease (Table II and see Table E6 ). The majority of autoimmune diseases showed examples of both the same and opposite directions of effect compared with allergy. For some of the common loci at which several autoimmune diseases have reported association, the different autoimmune diseases showed differences in direction of effect relative to allergy (HLA-B, BACH2, and RPS6KA4).
After gene set enrichment analyses of these 29 common loci, the resulting significant hits were all ontological terms relating to immune function, including immunoglobulin diversification and production, T-and B-cell activation, signaling by nuclear receptors, and abnormal immune cell physiology (Fig 2 and see Fig  E16 and Table E8 in this article's Online Repository at www. jacionline.org). Coloring for loci with same versus opposite directions of effect for allergy and autoimmune diseases showed no clear systematic differences (Fig 2) .
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To investigate whether the common loci seem to tag the same genetic variant, we performed regional association plots showing that, for almost all loci, the autoimmune disease-tagging SNP is also within the linkage disequilibrium block with the strongest regional association with allergy (see Fig E18 in this article' s Online Repository at www.jacionline.org). Tagging of the same genetic variation at common loci was further supported by means of paired comparison of regional association plots for Crohn disease 14 and allergy, respectively, for the most statistically significant common loci (see Fig E19 in this article' s Online Repository at www.jacionline.org).
Shared and differential genetic pathways for allergy and Crohn disease
A direct comparison of pathways targeted by allergy-related loci versus Crohn disease loci revealed a large proportion of both shared and disease-specific pathways, with a strong predominance of T cell-signaling modules within the shared grouping (Fig 3) .
DISCUSSION
Our study demonstrated substantial commonalities between allergy and autoimmune diseases in terms of susceptibility loci, genetic pathways, and genomic regulatory sites (DHS). This overlap in genetic mechanisms seemed to be a general phenomenon for allergy and autoimmune diseases and distinct from other diseases. Our study identifies a substantial number of novel overlapping loci for allergy and autoimmune diseases suggesting both shared (increasing risk of both autoimmune and allergic disease), as well as diverging genetic mechanisms.
Strengths and limitations
By combining 2 GWASs on allergic sensitization and allergic symptoms, respectively, we were able to obtain a powerful GWAS data set on allergy, which allowed a systematic analysis of the genetic commonalities of allergy and autoimmune diseases. The index disease used in the comparison of effect direction is shown as boldface and underlined. 1/2, Direction of effect for the autoimmune disease compared with the direction of allergy; A, arthritis; AS, ankylosing spondylitis; CeD, celiac disease; CrD, Crohn disease; FDR, false discovery rate; GD, Graves disease; IBD, inflammatory bowel disease; LD, linkage disequilibrium; MAF, minor allele frequency; MS, multiple sclerosis; NA, some diseases have not reported the effect allele; PBC, primary biliary cirrhosis; SLE, systemic lupus erythematosus; S, sarcoidosis; UC, ulcerative colitis; T1D, type 1 diabetes. *As reported by Bønnelykke et al. 10 Test for heterogeneity within the allergy meta-analysis. àReported traits associated with locus (autoimmune trait marker LD with allergy marker >0.6 and allergy marker P < .05). §Compared with index autoimmune disease (underlined and boldface in the Traits column)-SNP effect direction. kGenome-wide significant association to allergy/allergic sensitization reported by Hinds et al and/or Bønnelykke et al. 9, 10 {Suggestive association with asthma with hay fever reported by Ferreira et al. 32 #Suggestive association with asthma reported by Ferreira et al. 31 The clinical phenotypes are not identical, with allergic sensitization often being present without symptoms and vice versa, which can also be seen as a limitation of the study. However, the phenotypes are closely correlated genetically, as suggested from the initial publications of the individual GWASs showing highly consistent mutual replication of top SNPs between studies. 9, 10 The improved number of significant SNPs and higher number of genome-wide significant loci in the combined meta-analysis performed here compared with the individual GWAS results also underscore the validity of the combined meta-analysis approach. Furthermore, the common loci between allergy and autoimmunity generally showed similar results for the 2 allergy-related phenotypes (see Table E6 ), and the enrichment of autoimmune loci was also similar for both phenotypes (see Fig E5) , strongly suggesting that the conclusions of this study are not affected by the combination of allergy-related phenotypes.
In the primary analyses we combined GWAS loci from several autoimmune diseases. This was done to assess commonalities between allergy and autoimmune diseases in general and to obtain enough autoimmune loci and thereby statistical power to perform more systematic analyses. However, it should be noted that autoimmune diseases represent a heterogeneous group of diseases and that the genetic architecture of autoimmune genes seems to include shared but also differential and opposing genetic mechanisms. [33] [34] [35] Therefore we also performed separate enrichment analyses for the different autoimmune diseases, showing that enrichment for allergy-related loci seems to be the case for the majority of autoimmune diseases (see Table E9 in this article's Online Repository at www.jacionline.org).
It is a limitation that we did not have access to GWAS data for all autoimmune diseases. For the regional analyses of shared loci, a publicly available GWAS data set on Crohn disease was therefore used as a representative of autoimmune disease. It is a limitation of the analyses based on GWAS catalog markers that genotype chips and imputation panels and procedures differ between studies, adding marker coverage heterogeneity. We chose to include GWAS catalog markers independent of ethnicity to maximize numbers of loci. Enrichment analyses for the largest GWAS of autoimmune diseases performed in individuals of European descent showed similar results as the main analyses (Table E9 ) demonstrating that differences in ethnicity did not have major impact on our results.
Our study is also limited by differences in study size of GWASs on autoimmune diseases, meaning that the diseases in which the largest GWASs have been performed and the most loci have been discovered will have a relatively larger effect on the results of the analysis combining all autoimmune diseases. The number of reported loci for each autoimmune disease is shown in Table I .
Interpretation
We found substantial overlap of susceptibility loci for allergy and autoimmune diseases, suggesting commonalities in the genetic background and hence the possibility of shared pathogenetic mechanisms. The possible common etiology of allergy and autoimmune diseases was further supported by coclustering of autoimmune diseases, asthma, and allergy in terms of genetic pathways and regulatory sites, implying shared disease pathways beyond overlap of associated SNPs.
To our knowledge, no previous study has had sufficient statistical power to systematically explore commonalities in the genetic architecture between allergy and autoimmunity. One previous study found no association between susceptibility loci for type 1 diabetes and total IgE levels, 36 arguing against a shared genetic background. However, that study had much lower statistical power than the present study, and the genetics of total IgE have been shown to be different from those of allergen-specific IgE. 10 Another study compared results from a GWAS on asthma with published GWAS results on autoimmune diseases and found evidence of 7 overlapping susceptibility loci showing examples of both the opposite and same direction of effect for asthma and autoimmune diseases. 37 Importantly, our study demonstrates common loci with both same and opposite directions of effect, potentially pointing toward both converging (shared) and diverging (counteracting) mechanisms and either increasing the risk of both allergy and autoimmune diseases or increasing the risk for one of the diseases while protecting against the other. Our study thereby provides further understanding of the complex genetic relationship between allergy and autoimmune diseases. We hypothesize that common loci with the same direction of effect might be involved in mechanisms causing the contemporaneous epidemics of allergy and autoimmune disease 1 by increasing the susceptibility to immune disorders in general, through mechanisms involving gene-environment interaction. Complementarily, common loci with opposite directions of effect might be involved in mechanisms determining the type of immune disorder developing in the subject, resulting in the inverse relationship observed between allergy and some autoimmune diseases. [5] [6] [7] This could also help predict how targeting specific disease mechanisms could have the unintended consequence of increasing the risk of other diseases.
We expect loci with the same direction of effect to be of particular importance in the search for common mechanisms driving the parallel increases in disease incidence. Of specific interest are the loci at C11orf30, PLCL1, and SMAD3, which were strongly associated with both allergy and several autoimmune diseases. Of these, C11orf30 and SMAD3 were also identified in a previous study comparing asthma and autoimmune diseases. 37 Some of the loci with same direction of effect were linked to immune-related transcription factors (RORC and SMAD3), transcriptional cofactors (EP300), cell-cycle regulators (THADA), or regulators of transcription (C11ORF30, PLCL1, AKAP11, and NDFIP1). Several are directly implicated in regulation of regulatory T (Treg) cells (SMAD3 38 and EP300
39
) and T H 17 cells (RORC 40 and SMAD3 
38
) or regulation of immune activity (IL2RA). This supports a commonality of autoimmune and allergic diseases based on defects in immune suppressive functions. Other loci with the same direction of effect included CLEC16A, TNFSF11, CCR4, and GLB1, all of which are involved in immune function through different means.
Loci with opposite directions of effect might be involved in ''polarization'' of the immune response. Because allergy is acknowledged to involve T H 2-mediated pathology, whereas most autoimmune diseases involve both T H 1 cells and pathogenic T H 17 cells, any genetic factors that perturb T H cell differentiation ability or immunosuppressive Treg cell function might influence the risk of specific disease development. Loci with opposite directions of effect included LPP, NFKB1, and TNFAIP3, which are all involved in immune cell signaling and activation/deactivation processes. Several of the other loci with opposite directions of effect function as possible regulators of immune cell differentiation (HDAC7/VDR, 41, 42 IKZF3, SH2B3, BACH2, RPS6KA4, and MSK2
43
) and cell-cycle regulation (RAD51L1), whereas the remaining loci (C12ORF30, PSMG1, HLA-DPB2, and KIF1B) are more general regulators of cellular function. However, it should be noted that given the complexity of genetic regulation and the fact that the causal genetic variant is unknown for most susceptibility loci, the finding of common genetic loci with an apparent opposite direction of effect should be interpreted with caution. It is possible that this is the result of different underlying causal variants in the region, although comparison of regional association plots suggested that association signals for allergy and autoimmune disease tagged the same genetic variation. Potential polarizing mechanisms associated with these loci should be addressed in future studies, such as by demonstrating opposite disease relationships on levels of gene expression, protein levels, or both.
Gene set enrichment analyses of the 29 shared loci (Fig 2  and see Fig E16 and Table E5 ) indicate that immune functioning and activation status specifically within T cells represent a shared focal point for allergy and autoimmune diseases. Involvement of shared immunologic paths was supported further based on the type of transcription factors found to be enriched within the common loci at which generic immune regulatory transcription factors, including MTA3, WRNIP1, and IKZF1 (Ikaros), turned out to be central players (see Fig E17) . MTA3 has been shown to be involved in B-cell and T H cell differentiation, 44, 45 and WRNIP1 has been reported to regulate expression of transcription factors involved in Treg cell functioning. 46 IKZF1 activates extensive transcriptional programs involving especially regulation of T, B, and natural killer cells with effects on differentiation, proliferation, and apoptotic programs in these cell types. 47 Moreover, several other directly immune-related transcription factors were identified among the top 10 hits, including NFATC1, STAT2, MEF2C, RELA, SP2, and ZEB1. [48] [49] [50] [51] [52] [53] Comparative pathway analysis between allergy and Crohn disease highlights that the common pathways of these diseases are founded on (de)regulation of adaptive immune signaling, involving T-cell receptor, CD28, IL-2/IL-3/IL-5/IL-6, IFN-g, GM-CSF, Janus kinase/signal transducer and activator of transcription, and interleukin receptor signaling, as well as apoptosis and IgA production. The Crohn disease-specific network primarily included pathways associated with innate immune activation involving Toll-like receptor and nucleotidebinding oligomerization domain signaling, in which allergyspecific pathways were associated with signaling from receptor tyrosine kinases, such as epidermal growth factor receptor (Fig 3) .
A strong coclustering and separation of allergy, asthma and autoimmune diseases in terms of enrichment of SNPs in cell type-specific DHS sites point toward common immunemodulatory mechanisms facilitated by the effect of genetic SNP burden in immune cell-specific regulatory regions (see Figs E10 and E12). For allergy and Crohn disease, these related primarily to T-and B-cell function (see Fig E14) . In accordance with our findings of coinciding immune cell involvement in several immune-mediated diseases, one previous study on multiple sclerosis reported several genetic markers in relevant DHS sites in immune cells. 54 Accordingly and in line with our findings, a recent article focusing on autoimmune disease variants shows how these immune-mediated diseases are correlated and clusters in tendency for associated variants to be enriched in specifically immune cell enhancers. 55 Moreover, enrichment of immune cell-specific DHS sites specifically within promoter regions (see the Methods section and Fig E20 in this article' s Online Repository at www.jacionline.org) might be a result of the adaptability and immediate early gene response requirements of the immune system, and because their positioning is essential for gene expression levels, this might also explain why the identified specific SNP variants pose increased risk for disease penetrance.
In addition to pinpointing common loci between allergy and autoimmune diseases, our identification of common loci also suggests a large number of novel allergy loci; 18 of the 29 common loci have not previously been associated with allergy (Table II) . Our study suggests that these are all susceptibility loci for allergy that did not reach the criteria for genomewide significance and therefore were not discovered in previous GWASs.
Furthermore, our combined meta-analysis on allergy and allergic symptoms identified suggestive allergy loci, with several previously related to immune function (NFKB1 56 and CXCR5, 57 see Table E3 ). One novel allergy locus was discovered at rs11122898 and reached the genome-wide significance threshold. This locus is close to ANAPC1 but most likely affects the upstream MERKT gene (see Fig E21 in this article's Online Repository at www.jacionline.org), which is involved in regulation of dendritic cells through B-cell activating factor. 58 One additional suggestive locus was at ZBTB38, and genes within this family have been shown to have important function in naive B-cell differentiation 59 and been associated to eczema 60 and asthma with hay fever, 32 although it has not been shown that these genes are causal genes within these loci.
In conclusion, we performed the first large study on commonalities in the genetic origins of allergy and autoimmune diseases and documented substantial genetic overlap between these diseases. The recent availability of a vast array of genomics data from ENCODE and other consortia provides a solid foundation for systems biology analysis in disease settings. Exploiting this approach, we identified common molecular pathways between allergy and autoimmune diseases, identical patterns of overlaps with open chromatin specifically within immune cell-specific regulatory regions, and overlap in transcription factor binding sites, emphasizing common characteristics in gene regulation. Further investigation of these commonalities in genetic mechanisms might improve our understanding of important biological pathways that increase the risk of allergy and autoimmune diseases, as well as mechanisms differentiating these diverse diseases. Understanding of potential shared genetic origins of allergy and autoimmune diseases, maybe particularly related to the loci with the same direction of effect, could point to vulnerable ''hot'' points in immune system pathways that might also be affected by other modifiers, such as epigenetics and environmental exposures. This insight might provide important clues for understanding the parallel epidemics of these diseases and thereby enforce future disease prevention.
Key messages
d Allergy and autoimmune diseases share genetic susceptibility loci.
d These results indicate commonalities in gene regulation and genetic pathways between patients with allergy and those with autoimmune diseases.
